Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program 70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three major barriers to bending the obesity curve in the US: excessive US prices of medication, medication side effects, and sustainable lifestyle change NEW YORK, Aug
Sun F, Wu S, Guo S, Yu K, Yang Z, Li L, et al
The peptide becomes susceptible to both chemical degradation and physical instability (aggregation)
Huang J, Liu Y, Cheng L, Li J, Zhang T, Zhao G, Zhang H
2 Less than 1% of patients in an efficacy and safety trial reported a skin adverse event
Academic institutions, independent research organizations, or collaborative pharmaceutical initiatives could theoretically pursue these questions, though competitive dynamics make such studies unlikely in the near term